Product Reports Resources Pricing Login Book a demo

Pear Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2013 · Public via SPAC 2021

Pear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need

Valuation $690K
Revenue $13M
Power Law Unicorn$1–10B valuation tier
Featured in
Market map Global Consumer Mental Health companies Market map Digital therapeutics

Investors

17 investors on Pear Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage
JAZZ Venture Partners
Bridge Builders Collaborative
Arboretum Ventures
Novartis
5AM Ventures
Series B+ 12 investors entered at this stage
University of Virginia
Temasek
Shanda Group
QUAD Investment Management
Pilot House Ventures
EDBI
Dartmouth College
Karolinska Institute
SoftBank
SoftBank Vision Fund
Trustbridge Partners
University of Southern California

Pear Therapeutics mafia

Startups founded by Pear Therapeutics alumni

Former Pear Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

Aurenar, IncEst. 2023
Eric LeuthartUnited States
Signal score82
Affini-T TherapeuticsEst. 2020
Arjun GoyalUnited States
Signal score62
New Frontier BioEst. 2020
SSStephen SmithUnited States
Signal score61
VirtualnessEst. 2022
Kirthiga ReddyUnited States
Signal score55

Book a demo to explore the full alumni network →

Global footprint

Where Pear Therapeutics has talent and traffic

Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown
Web traffic by country
410 monthly visits
across markets
🇪🇬 Egypt97.6%
Top 1 markets shown

Talent graph

The shape of Pear Therapeutics's talent

Dealroom maps Pear Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Pear Therapeutics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$10M patent portfolio · 8 active families

Estimated portfolio value
$10M
1443.5% of market cap · 97× smaller than top peer Globus Medical ($966M)
8 active patent families
Where Pear Therapeutics innovates Behavioral therapyData processingData scienceElectric devicesElectronic equipment

Where Pear Therapeutics concentrates vs peers

Each axis is a top-10 topic across Pear Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Pear Therapeutics

An AI-synthesized read of the highest-engagement posts about Pear Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pear Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles